Ocular Therapeutix (OCUL) Change in Inventory (2014 - 2026)
Ocular Therapeutix's (OCUL) quarterly Change in Inventory came in at $173000.0 in Q1 2026, down 24.45% year-on-year from $229000.0 in Q1 2025, and up 127.63% quarter-over-quarter from $76000.0 in Q4 2025.
Ocular Therapeutix (OCUL) Change in Inventory (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Change in Inventory history runs 13 years deep, the most recent figure standing at $173000.0 for Q1 2026.
- On a quarterly basis, Change in Inventory fell 24.45% year-over-year to $173000.0 in Q1 2026; TTM through Mar 2026 was $468000.0, a 32.66% decrease from a year earlier, with the FY2025 full-year figure at $524000.0, down 28.71% from the prior year.
- Change in Inventory grew to $173000.0 in Q1 2026 per OCUL's latest filing, from $76000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $635000.0 in Q4 2024 and bottomed at -$230000.0 in Q2 2025.
- The 5-year median for Change in Inventory is $108000.0 (2022), against an average of $146294.1.
- Across the five-year window, Change in Inventory surged 1432.14% in 2022 and plunged 751.85% in 2025, its largest moves.
- Year by year, Change in Inventory stood at $429000.0 in 2022, then plunged by 88.81% to $48000.0 in 2023, then jumped by 1222.92% to $635000.0 in 2024, then slumped by 88.03% to $76000.0 in 2025, then surged by 127.63% to $173000.0 in 2026.
- Per Business Quant, the three latest OCUL Change in Inventory figures stand at $173000.0 (Q1 2026), $76000.0 (Q4 2025), and $449000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Dec 31, 2025 | 76,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Sep 30, 2025 | 449,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Jun 30, 2025 | -230,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Mar 31, 2025 | 229,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Dec 31, 2024 | 635,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Sep 30, 2024 | -142,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -27,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Mar 31, 2024 | 269,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |